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Early onset sepsis due to group B streptococcus leads to neonatal morbidity, increased mortality, and long-term neurological
deficencies. Interaction between septicemic GBS and confluent monolayers of human coronary artery endothelial cells (HCAECs)
was analyzed by genome wide expression profiling. In total, 124 genes were differentially expressed (89 upregulated, 35
downregulated) based on a more than 3-fold difference to control HCAEC. Regulated genes are involved in apoptosis, hemostasis,
oxidative stress response, infection, and inflammation. Regulation of selected genes and proteins identified in the gene array
analysis was confirmed by Real-time RT-PCR assay (granulocyte chemotactic protein 2), ELISA (urokinase, cyclooxygenase 2,
granulocyte chemotactic protein 1), and western blotting (Heme oxygenase1, BCL2 interacting protein) at various time points
between 4 and 24 hours. These results indicate that GBS infectionmight influence signalling pathways leading to impaired function
of the innate immune system and hemorrhagic and inflammatory complications during GBS sepsis.
1. Introduction
Pneumonia, sepsis, meningitis due to infection with GBS
are common causes of morbidity, mortality, and long-term
neurological sequelae in neonates [1]. Vaginal smears of
up to 40% of pregnant women show colonization with S.
agalactiae, 50 to 70% of their children will be colonized
postpartum [2, 3]; up to 2 newborns per 1000 live births
will develop GBS infection [4, 5], which is characterized
by unspecific clinical signs such as temperature instability,
respiratory distress, palor, and abdominal symptoms. The
majority of neonates develop early onset sepsis within the
first 24 hours of life, which rapidly progresses in septic shock
and hemorrhage. Depending on the gestational age, case
fatality rate can increase up to 30 percent in preterm infants
<32 weeks of gestation [6, 7]. More than 50% of affected
newborns suffer from neurological deficencies like sight or
hearing loss and mental retardation. In addition 19,000 cases
of GBS disease occur annually in the United States, and
up to 35% of the symptomatic infections in elderly and
immunosuppressed patients suffer from chronic diseases [8].
GBS has characteristic virulence factors, including the
ability to bind to extracellular matrix components, such as
fibronectin, fibrinogen, and laminin [9], allowing to pass
cellular barriers and to become invasive.
Following bacteremia, immune response is partially
insufficient, presumably due to immature innate immunity
of the neonate [10]. Lipopolysaccharides of Gram negative
bacteria are able tomodify the barrier function of endothelial
cells [11]. Lembo et al. could previously demonstrate that
GBS are able to penetrate the blood-brain barrier by
targeting human brain microvascular endothelial cells [12].
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However it is unclear if GBS is also able to invade human
coronary artery endothelial cells. Endothelial dysfunction is
a major component in the pathophysiology of septicemic
GBS infection [13, 14]. Therefore, analysis of the interaction
between GBS and endothelial cells is of major interest,
especially the septic and haemorrhagic complications in
newborns. Genome wide expression profiling allows detailed
insights in the pathogenesis of GBS sepsis and helps to better
understand the underlying pathophysiological mechanisms.
We studied the interaction between human coronary
artery endothelial cells (HCAECs) and S. agalactiae by
genome wide high density microarrays. The results of this
study indicate that GBS are able to regulate transcription of
a wide range of genes, involved in infection, inflammation,
and apoptosis.
2. Materials andMethods
2.1. Bacterial Strain. Streptococcus agalactiae Lancefield’s
group B (ATCC13813 strain Lehmann and Neumann,
serotype V, septic, nonhemolytic) was obtained from
ATCC (LGC Promochem, Wesel, Germany). Bacteria were
grown overnight on tryptic-soy agar plates supplemented
with 5% sheep blood (Institut fu¨r Hygiene und Medizinische
Mikrobiologie, University of Wuerzburg, Germany) and cul-
tured in 20ml lysogeny broth (LB) medium, supplemented
with 1% trypton, 0,5% yeast extract, and 1% NaCl at 37◦C
for 90 minutes. A final bacteria concentration of 2 to 4 ×
109/ml was achieved after adjustment of the optical density
at 600 nm.
2.2. Endothelial Cell Culture. Primary human coronary
artery endothelial cells (HCAECs, cryopreserved, third pas-
sage) were obtained from Lonza (Basel, Switzerland) and
cultured in EBM2 medium (Lonza), and supplemented with
EGM-2-MV singleQuots (Lonza) with 5% FBS. Endothelial
cells were incubated at a humified atmosphere of 5%CO2
at 37◦C. All cells were subcultured at a 1 : 6 ratio and were
used for experiments from passages 5 to 16. After reaching
80% confluence, endothelial cells were washed three times
with phosphate buffered saline (PBS) and detached from
culture flasks using Trypsin-EDTA solution. The reaction
was stopped with TNS solution (Cambrex), and cells were
resuspended in complete medium.
2.3. HCAEC Infection. GBS, diluted in LB medium, were
added in multiplicity of infection (MOI) of 20 to HCAEC.
LB medium with HCAEC was used as uninfected controls.
For gene array analysis, cells were trypsinised, resus-
pended in trypsin neutralization solution (TNS, Cambrex),
and centrifuged at 800 rpm for 5 minutes after 6 hours
of infection, because preliminary data have shown that
the maximum of gene regulation occurs between 4 and 8
hours. For additional conformation experiments, infection
was stopped after 4, 8, and 24 hours. Confirmation of gene
array data was selectively carried out by Real-time RT-PCR,
western blot analysis, and ELISA at different time points. For
Real-time RT-PCR HCAECs were detached from cell culture
dishes by a cell scraper, snap-frozen and stored at −80◦C
until RNA isolation.
For western blotting, protein extracts were prepared by
detaching cells, followed by centrifugation at 800 rpm for 5
minutes. Cell pellets were carefully washed once with 4ml
phosphate buffered saline solution (PBS) and centrifuged
again. Cells were resuspended in 100 μl PBS and 100 μl SDS
stop solution (200mM Trizma-Base pH 6.7, 15% Glycerin,
0,03% bromphenole blue, 6% sodium dodecyl sulfate (SDS),
ß-mercaptoethanol, 9 : 1, 95◦C) for 5 minutes at 95◦C. Until
further analysis, protein extracts were stored at −20◦C.
In parallel, cell culture supernatants were collected and
frozen at −20◦C until further analysis by ELISA (uPA). For
IL-8 and CXCL-6 ELISA, cells were detached in 150 μl PBS,
snap-frozen, and stored at −80◦C.
2.3.1. RNA Extraction, cDNA Synthesis, and Array Analysis.
For RNA extraction, cell pellets were resuspended in ß-
mercaptoethanol and RLT lysis buffer (Qiagen, Hilden,
Germany). For disruption and homogenization lysates were
loaded on QiaShredder spin columns (Qiagen) and cen-
trifuged at 13.000 g for 2min. RNA purification was carried
out using RNeasy spin columns (Qiagen) according to the
protocol of the manufacturer. RNA was eluted in 35 μl
RNAse-free water, and RNA concentration was determined
photometrically (Nanodrop ND-1000, NanoDrop Technolo-
gies, Wilmington, USA).
For gene array analysis, quality of RNA was deter-
mined using a BioAnalyzer (Agilent Technologies, Wald-
bronn, Germany), and RNA integrity numbers (RINs) were
between 9.6 and 9.7. Two μg of total RNA were reverse
transcribed, performing second strand synthesis (One-Cycle
cDNA synthesis Kit, Affymetrix, Santa Clara, USA). Syn-
thesis of biotinylated cDNA was carried out using the IVT
Labelling Kit (Affymetrix). Fifteen μg of the fragmented,
labelled cRNA were hybridized to Affymetrix HG-U133
Plus 2.0 arrays. Fluorescence intensity was measured by a
GeneChip Scanner 3000 (Affymetrix). For normalization
and data analysis, software from the bioconductor project
(http://www.bioconductor.org/) was used. After normaliza-
tion by variance stabilization [15], data quality was verified
by density plots, degradation plots, and box plots. Data anal-
ysis was based on a more than 3-fold difference compared
to unstimulated HCAEC. Resulting genes were functionally
clustered according to Gene Ontology using Gene Ontology
Tree Machine (GOTM) (http://dbmi.mc.vanderbilt.edu/).
For Real-time RT-PCR, cDNA synthesis was performed
using the QuantiTect Reverse Transcription kit (Qiagen) for
25 minutes at 42◦C and 3 minutes at 95◦C. cDNA was stored
at −20◦C until further analysis.
2.4. Real-Time RT-PCR. Quantitative Real-time RT-PCR for
CXCL6, TLR2, and TLR4 quantification was carried out using
the LightCycler instrument. To normalize Real-time PCR
data, serially diluted cDNA copies of the housekeeping gene
δ-aminolevulinic acid synthase (h-ALAS) were coamplified.
Analysis was performed comparing the number of cDNA
copies of the samples with the h-ALAS copies in each
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Table 1: Differential expression of selected genes Confirmation of gene expression profiles of the 6 listed selected genes was performed by
Real-time RT PCR, western blot or ELISA assays.
Downregulated genes
Gene Regulation [fold]
Interleukin 8 3,9
Chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) 3,9
Upregulated genes
Gene Regulation [fold]
Heme oxygenase (decycling) 1 10,7
Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 9,9
BCL2-like 11 (apoptosis facilitator) 6,0
Plasminogen activator, urokinase /// plasminogen activator, urokinase 3,4
sample, respectively. 45 cycles of repeated denaturation
(95◦C 9 sec), annealing (54◦C 15 sec), and elongation (72◦C
25 sec) were performed [16]. The PCR Mastermix (Light-
Cycler Fast Start Master Hybridization, Roche, Mannheim,
Germany) contained 0,125 μM of each primer (CXCL6:
5′-ttgcacttgtttacgcgtt, 5′-tcagtttttcttgtttccactgt; TLR2: 5′-
tgtcttgtgaccgcaatggta, 5′-gcttgaaccaggaagacgat; TLR4: 5′-
ggagccctgcgtggaga, 5′-tatgccccatcttcaattgtc) and 0,15 μM of
the hybridization probes (CXCL6: 5′-gcaagtttgtctggacccgga-
FL, 5′-LC640-gccccttttctaaagaaagtcatccagaa-p; TLR2: 5′-cta-
cagaggtgtgtgaacctccaggc-FL, 5′-LC640-ctggtgctgacatccaat-
ggaattaac-p; TLR4: 5′-cccttcaccccgattccattgct-FL, 5′-LC640-
cttgctaaatgctgccgttttatcacg-p), labeled with fluorescein and
LC Red 640, respectively.
2.5. Western Blotting. Cellular proteins were loaded onto
SDS-polyacrylamid stacking gels (3%), separated in running
gels (12%), and run for 1 hour at 160V in Tris-SDS-glycine
electrophoresis buffer according to Laemmli. Proteins were
electrotransferred to polyvinylidene fluoride membranes
(Immobilion-P 45 μm, Millipore, Bedford, USA) at 1 A for
60 minutes at 4◦C. After being blocked for one hour in
Tris Buffered Saline/Tween (25mM Tris pH7.6, 150mM
NaCl, 0,05% Tween20) containing 6% dry milk, membranes
were incubated with primary antibodies (HMOX-1: 1 : 250,
milk, mouse, BD Bioscience Pharmingen, San Jose, USA;
Bim: 1 : 100, milk, rabbit, BD Bioscience Pharmingen)
overnight at 4◦C. Membranes were washed briefly and incu-
bated with horse-raddish-peroxidase-conjugated antirabbit
or antimouse IgG (goat anti-mouse/rabbit HRP, 1 : 3000,
milk, goat, Bio-Rad, Munich, Germany) for one hour at
room temperature. Immunoreactivity was detected using
an ECL or ECL-plus detection kit (Amersham pharmacia
biotech, Freiburg, Germany). The protein bands on X-ray
films (Fuji Photo Film GmbH, Du¨sseldorf, Germany) were
scanned, and the intensity of bands was analyzed using
NIH Image software (version 1.61). Loading control was
performed with ß-actin (1 : 20, milk, rabbit, Santa Cruz
Biotechnology Inc., Santa Cruz, USA).
2.6. Protein Quantification by ELISA. COX2 (TiterZyme
EIA, Assay Designs, Inc., Michigan, USA), IL-8 (Quan-
tikine kit, R&D Systems, Wiesbaden, Germany), and uPA
(IMUBIND, American Diagnostica, Stamford, USA) levels
were quantified by ELISA, according to the suppliers pro-
tocol. Mean fluorescence was quantified by measurement
of optical density, using the SoftMax System (Molecular
Devices GmbH, Ismaning, Germany).
2.7. Data Analysis. Data represent means +/− standard
errors of the means (SEM). Differences between groups were
tested using Student’s t-test. Differences were considered to
be significant at P < .05. Confirmation experiments were
repeated 3 to 5 times.
3. Results
3.1. Gene Expression Patterns of HCAEC after Infection with
S. agalactiae. In total, 124 genes were differentially expressed
(89 upregulated, 35 downregulated) based on a more than
3-fold difference to control HCAEC (see Supplementary
Material available online at doi: 10.1155/2011/971502).
Signal log ratios (base e) varied between −2.7 and 1.5
comparing control cells versus HCAEC after 6 hours
of coincubation with S. agalactiae. The highest level of
induction was observed for genes encoding transcriptional
regulation (14.3-fold upregulated); the highest level of
inhibition was achieved in genes involved in DNA-specific
binding (4.5-fold downregulated). Raw data are available at
http://www.ncbi.nlm.nih.gov/projects/geo/, accession num-
ber: GSE15495.
Differencial expression of selected genes (Table 1) was
validated by one additional method, includingWestern blots,
Real-time RT PCR, and ELISA assays. We selected regulated
genes, which are involved in apoptosis, hemostasis, oxidative
stress response, infection, and inflammation for further
analysis.
3.2. Upregulation of the BCL2-Like-Interacting Protein (Bim)
by GBS. Bim belongs to the group of proapoptotic BCL2
members. The initiation of apoptosis after GBS infection
is still largely unknown. Previously, we could demonstrate
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cleavage of Caspases 3 and 8 after infection of HCAEC with
S. agalactiae (data unpublished).
Expression of Bim was demonstrated by Western blot
analysis of cell culture lysates. Bim protein levels were
increased by 1.3-fold after 4 hours, 1.5-fold after 8 hours, and
2.6-fold after 24 hours of infection, compared to uninfected
cells (Figure 1).
3.3. Upregulated Expression of the Heme-Oxygenase-1
(HMOX-1) by GBS. Heme oxygenase 1 plays an important
role in the regulation of apoptosis and cell protection during
inflammatory processes. Expression of HMOX-1 is species-
and cell-specific, induced by oxidative stress, due to LPS,
ischemia, or cytokines [17].
Infection of HCAEC with the septicemic S. agalactiae
strain ATCC 13813 led to HMOX-1 upregulation,
compared to unstimulated cells (2.3-fold after 4 hours, 4.7-
fold after 8 hours, and 6.6-fold after 24 hours of infection,
Figure 2).
3.4. Downregulation of CXCL6 by Real-Time RT PCR.
CXCL6 is a strong mediator of inflammation, attracting
mainly neutrophils [18], but also eosinophils, lymphocytes,
and monocytes [19]. CXCL6 production can be induced by
IL-1-ß, TNF-alpha, hypoxemia, and LPS [20].
Downregulation of CXCL6 after GBS stimulation was
observed (2-fold after 4 hours and 12.9-fold after 8 hours of
infection). After 24 hours of infection, no CXCL6-RNA was
detectable (Figure 3).
3.5. Downregulation of TLR2 and TLR4 by Real-Time RT PCR.
TLR 2 and TLR4 are major receptors of the human innate
immune response against various pathogens, interacting
with lipoteichoic acid and bacterial LPS, respectively [21].
TLR4 expression was reduced after GBS stimulation (3.4-
fold after 4 hours, 2.9-fold after 8 hours, and 11-fold after
24 hours of infection). We also observed downregulation of
TLR2 (4.3-fold after 4 hours, 3.8-fold after 8 hours, and 1.2-
fold after 24 hours of infection, Figure 4) .
3.6. Downregulation of Interleukin 8 (IL-8) in Cell Culture
Lysates. Interleukin 8, a member of the CXC chemokine
superfamily, attracts neutrophils and monocytes to sites of
inflammation. Production of IL-8 can be induced by differ-
ent cytokines, viral infections, or gram negative bacteria [22].
IL-8 secretion was reduced by factor of 2.5 (4 h), 1.7 (8 h),
and 1.5 (24 h).
3.7. Upregulation of Urokinase (uPA) in Cell Culture Super-
natants. Urokinase regulates fibrinolysis by plasminogen
activation. Therefore, hemorrhagic dysregulation, observed
in GBS infected neonates might be enhanced from the
observed upregulation of urokinase. We found upregulation
in urokinase levels in HCAEC cell culture supernatants (1.6-
fold after 4 hours, 2.6-fold after 8 hours, and 3.7-fold after 24
hours of infection, Figure 5).
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Figure 1: Time course of Bim upregulation in HCAEC induced
by GBS. (a) Autoradiograph of western blot analysis of cell culture
lysates demonstrating upregulation of Bim after 4, 8, and 24 h in
comparison to unstimulated HCAEC. (b) Quantitative analysis of
the Bim signaling pathway. Data shown represent mean expression
in percent ± the standard error of the mean (SEM) of up to 4
independent experiments. The results after 8 hours are defined as
100 percent. ∗ Indicates statistical significant difference (P < .05);
n.s.: no significant difference.
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Figure 2: Time course of HMOX-1 upregulation in HCAEC
induced by GBS. (a) Autoradiograph of western blot analysis of cell
culture lysates demonstrating upregulation of HMOX-1 after 4, 8,
and 24 h in comparison to unstimulated HCAEC. (b) Quantitative
analysis of the HMOX-1 signaling pathway. Data shown represent
mean expression in percent ± SEM of up to 4 independent
experiments. The results after 8 hours are defined as 100 percent.
∗ Indicates statistical significant difference (P < .05); n.s.: no
significant difference.
Mediators of Inflammation 5
∗
∗
0.25
0.2
0.15
0.1
0.05
0
0 4 8
Time (h)
ATCC
C
X
C
L6
(r
el
at
iv
e
n
or
m
al
iz
ed
ex
pr
es
si
on
)
Figure 3: Gene expression of CXCL6 was analyzed by quantitative
Real-time RT-PCR. Data shown represent normalized mean expres-
sion of CXCL6 ± SEM of up to 4 independent experiments. CXCL6
expression was normalized against h-ALAS housekeeping-gene. ∗
Indicates statistical significant difference (P < .05).
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Figure 4: Gene expression of TLR2 and TLR4 was analyzed
by quantitative Real-time RT-PCR. Data shown represent mean
expression of TLR2 and TLR4 in percent. TLR expression was nor-
malized against h-ALAS housekeeping-gene. ∗ Indicates statistical
significant difference (P ≤ .05).
3.8. Upregulation of Cyclooxygenase-2 (COX2) in Cell Culture
Lysates. COX2 is induced during inflammation among oth-
ers in macrophages, monocytes as well as in endothelial cells
[23]. No data are known about COX2 induction in HCAEC
after GBS infection.
We observed a weak upregulation of COX2 expression
after 8 hours of infection (1.5-fold), whereas COX2 levels
remained unchanged after 4 and 24 hours of infection
compared to uninfected HCAEC.
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Figure 5: Time course of uPA production by HCAEC coincubated
with GBS. uPA released from HCAEC was determined in the cell
culture supernatants by ELISA as described in section 2. Data shown
represent mean production in percent ± SEM of 3 independent
experiments. The unstimulated control is defined as 100 percent.
∗ Indicates statistical significant difference (P < .05).
4. Discussion
The present study demonstrates the use of cDNA microar-
ray technology to characterize transcriptional responses in
HCAEC coincubated with GBS.
The major new findings of this study are as follows. (i)
GBS is capable to differentially regulate genes in HCAEC.
(ii) GBS leads to upregulation of the proapoptotic BCL2-
like-interacting protein (Bim) and of heme-oxygenase-
1 (HMOX-1). (iii) GBS causes downregulation of the
chemokines CXCL6 and IL-8. (iv) Urokinase (uPA) and
cyclooxygenase-2 (COX2) were activated after GBS infection.
Doran et al. [24] performed a study analyzing the inter-
action between S. agalactiae and human brain microvascular
endothelial cells. In contrast to our study, this group used a
haemolytic strain and revealed ß-hemolysin/cytolysin as the
most important pathophysiological player in amurinemodel
of hematogenous meningitis.
Our data show that the proapoptotic protein Bim is
upregulated during the course of GBS infection. One reason
for Bim upregulation during infection with S. agalactiae
could be elevated levels of cytokines and chemokines in
HCAEC [25]. Bim might cause the release of mitochondrial
cytochrome c, activating the intrinsic way of apoptosis
induction [25]. Our own previous results (data unpublished)
indicate that GBS can cause a breakdown of the mitochon-
drial membrane potential in HCAEC, reflecting an initiation
of programmed cell death.
Activation of Toll-like receptors leads to an augmented
phosphorylation and inactivation of Bim, which in conse-
quence avoids apoptosis [26]. Our group was able to demon-
strate a downregulation of TLR2 and TLR4 after infection
with the septicemic GBS strain ATCC 13813 after 4 h, 8 h,
and 24 h, respectively, compared to unstimulated cells. GBS-
induced downregulation of TLR4 might be responsible for
Bim-induced apoptosis, which might support tissue invasion
of GBS.
According to Smith et al. [27], who observed an upreg-
ulation of HMOX-1 after stimulation with Streptococcus
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pneumoniae, we could demonstrate activation of HMOX-1 in
HCAEC coincubated with Streptococcus agalactiae.After acti-
vation, HMOX-1 cleaves hemoglobin into carbon monoxide
(CO), iron (Fe2+), and biliverdin, followed by conversion
into bilirubin [28]. All degradation products of heme can
potentially be both toxic and protective. Carbonmonoxide
leads to vasodilatation and lower inflammatory response
[29]. Furthermore, CO impairs platelet aggregation.
Our own group could previously demonstrate that GBS
is able to induce platelet aggregation [30]. In consequence,
upregulated expression of HMOX-1 could reflect a protective
mechanism against thrombotic complications after infection
with GBS.
In addition, overexpression of HMOX-1 might lead to
elevated bilirubin levels [30], potentially interfering the
change from fetal to adult hemoglobin [31]. Hyperbiliru-
binemia might be responsible for neurological long-term
sequelae, observed after GBS newborn infections [32].
Furthermore HMOX-1 could indirectly and directly inhibit
apoptosis by minimizing reactive oxygen species (ROS) [33]
and by regulation of NFκB signaling [34]. In summary,
induction of HMOX-1 by GBS could represent a response
of HCAEC to GBS-induced pathomechanisms such as
apoptosis and inflammation.
CXCL6, which encodes a strong chemotactic protein
mainly for neutrophils, was markedly downregulated in
HCAEC after infection with S. agalactiae. Impaired CXCL6
levels could be responsible for lower neutrophil recruitment
and activation during GBS sepsis. In addition, CD4 positive
T-cells, activated by CXCL6, secrete augmented levels of IgG,
leading to opsonisation of microorganisms and thereby to
facilitated phagocytosis [35]. In parallel to CXCL6, a further
chemokine, IL-8, was downregulated after GBS infection,
potentially leading to impaired chemotaxis of monocytes
and neutrophiles. Futhermore, our own data revealed
that production of a third chemotactic protein, monocyte
chemoattractant protein (MCP)-1, was downregulated after
incubation with S. agalactiae unpublished. Taken together,
these results indicate either a mechanism of the host to avoid
excessive inflammation or a bacterial strategy to suppress
innate immune response.
The serine protease urokinase plays an important
role in fibrinolysis by activating plasminogen to plas-
min. Urokinase-type plasminogen activator upregulation
might explain the simultaneously observed hemorrhagic and
thrombotic complications during GBS sepsis [30]. Coculti-
vation of HCAECwith S. agalactiae revealed marked upregu-
lation of urokinase, as determined by ELISA assays. Elevated
urokinase levels could lead to resolution of platelet-bacteria-
thrombi resulting in facilitated tissue invasion of GBS.
In parallel to urokinase, we found a second thrombolytic
factor, cyclooxygenase 2, to be upregulated during GBS
infection, whereas COX1 is known to be constantly expressed
[36]. Imbalance of prostacyclin (produced by COX2) and
thromboxane A2 (produced by COX1) might be responsible
for hemorrhagical complications [37]. Prostacyclin-induced
vasodilatation might facilitate spread of bacteria in the
blood vessel system. Interestingly, COX2 levels were only
weakly increased after 4 hours of infection. Infection with a
highly septicemic bacteria strain leads to marked increase of
cyclooxygenase 2 expression [38]. However, in this study the
authors used LPS and macrophages.
In summary, our data demonstrates that S. agalactiae
might be able to escape innate immune mechanisms and to
induce hemorrhagical complications in HCAEC. Induction
of apoptosis, bleeding, and vasodilatation could explain the
invasive growth during GBS sepsis.
Knowledge of molecular mechanisms during GBS infec-
tion will contribute to a broader understanding of the
interaction of streptococci with the endothelium and, in con-
sequence, will support the development of new therapeutical
strategies against this severe complication.
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